11q22.2q22.3 microdeletion syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:444002Q93.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

11q22.2q22.3 microdeletion syndrome is a rare genetic condition caused by a small missing piece of chromosome 11, in a region called 11q22.2 to 11q22.3. This deletion means that several genes in that area are either missing or not working properly, which can affect how the brain, body, and organs develop. The condition is sometimes referred to simply as a chromosome 11q deletion or 11q22 microdeletion. People with this syndrome often show signs from birth or early childhood. Common features include intellectual disability, delayed speech and language development, and learning difficulties. Some individuals also have physical differences such as unusual facial features, low muscle tone (called hypotonia), and problems with growth. Heart defects and behavioral challenges, including features similar to autism spectrum disorder, have also been reported in some cases. There is currently no cure for 11q22.2q22.3 microdeletion syndrome. Treatment focuses on managing symptoms and supporting development. This usually involves a team of specialists and therapies such as speech therapy, occupational therapy, and physical therapy. Early intervention is very important and can make a meaningful difference in a child's development and quality of life.

Also known as:

Key symptoms:

Intellectual disability or learning difficultiesDelayed speech and language developmentLow muscle tone (hypotonia)Distinctive facial featuresSlow growth or short statureBehavioral challenges, including features of autismHeart defects (in some individuals)Feeding difficulties in infancyDelayed motor milestones such as sitting or walking lateSeizures (in some individuals)

Clinical phenotype terms (44)— hover any for plain English
Autism with high cognitive abilitiesHP:0000753
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 11q22.2q22.3 microdeletion syndrome.

View clinical trials →

No actively recruiting trials found for 11q22.2q22.3 microdeletion syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 11q22.2q22.3 microdeletion syndrome community →

No specialists are currently listed for 11q22.2q22.3 microdeletion syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 11q22.2q22.3 microdeletion syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 11q22.2q22.3 microdeletion syndromeForum →

No community posts yet. Be the first to share your experience with 11q22.2q22.3 microdeletion syndrome.

Start the conversation →

Latest news about 11q22.2q22.3 microdeletion syndrome

No recent news articles for 11q22.2q22.3 microdeletion syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What genes are missing in my child's deletion, and what does that mean for their health?,Should my child's heart be checked, and how often?,What therapies should we start right away, and how do we access them?,Is there a risk that other family members carry this deletion?,What signs should prompt me to seek emergency care?,Are there any clinical trials or research studies we could participate in?,What educational supports should we ask for at school?

Common questions about 11q22.2q22.3 microdeletion syndrome

What is 11q22.2q22.3 microdeletion syndrome?

11q22.2q22.3 microdeletion syndrome is a rare genetic condition caused by a small missing piece of chromosome 11, in a region called 11q22.2 to 11q22.3. This deletion means that several genes in that area are either missing or not working properly, which can affect how the brain, body, and organs develop. The condition is sometimes referred to simply as a chromosome 11q deletion or 11q22 microdeletion. People with this syndrome often show signs from birth or early childhood. Common features include intellectual disability, delayed speech and language development, and learning difficulties. So

At what age does 11q22.2q22.3 microdeletion syndrome typically begin?

Typical onset of 11q22.2q22.3 microdeletion syndrome is neonatal. Age of onset can vary across affected individuals.